NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A

The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway

(2016) Weiliang Jiang et al.   CANCER LETTERS

CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways

(2015) Jibin Li et al.   JOURNAL OF HEPATOLOGY

Circadian redox oscillations and metabolism

(2015) Nikolay B. Milev et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Lack of Association of the NPAS2 Gene Ala394Thr Polymorphism (rs2305160:G>A) with Risk of Chronic Lymphocytic Leukemia

(2014) Sobia Rana et al.   Asian Pacific Journal of Cancer Prevention

Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer

(2014) Xiaofeng Xue et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Functional polymorphisms in theNPAS2gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients

(2014) Peng Yuan et al.   CANCER SCIENCE

Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms

(2014) Annette Brenner et al.   MOLECULES

Circadian pathway genes in relation to glioma risk and outcome

(2013) Melissa H. Madden et al.   CANCER CAUSES & CONTROL

Circadian molecular clocks and cancer

(2013) Fergal C. Kelleher et al.   CANCER LETTERS

CDC25A targeting by miR-483-3p decreases CCND–CDK4/6 assembly and contributes to cell cycle arrest

(2013) T Bertero et al.   CELL DEATH AND DIFFERENTIATION

The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis

(2012) Tao Shen et al.   Anti-Cancer Agents in Medicinal Chemistry

The circadian clock geneBMAL1is a novel therapeutic target for malignant pleural mesothelioma

(2012) Momen Elshazley et al.   INTERNATIONAL JOURNAL OF CANCER

Circadian Integration of Metabolism and Energetics

(2010) J. Bass et al.   SCIENCE

The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer

(2009) Chunhui Yi et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis

(2009) Chun-Hui Yi et al.   CANCER LETTERS

A Role for the Clock Gene Per1 in Prostate Cancer

(2009) Q. Cao et al.   CANCER RESEARCH

A review of human carcinogens—Part F: Chemical agents and related occupations

(2009) Robert Baan et al.   LANCET ONCOLOGY

Regulation of Bcl-2 Family Proteins by Posttranslational Modifications

(2008) Anthony Letai et al.   CURRENT MOLECULAR MEDICINE

The Circadian Gene NPAS2, a Putative Tumor Suppressor, Is Involved in DNA Damage Response

(2008) A. E. Hoffman et al.   MOLECULAR CANCER RESEARCH